Clearpoint Neuro Inc expected to post a loss of 20 cents a share - Earnings Preview
08/03/2024 21:10
* Clearpoint Neuro Inc CLPT.OQ CLPT.O is expected
to show a
rise in quarterly revenue when it reports results on March 12
for the period ending December 31 2023
* The Solana Beach California-based company is expected to
report
a 26.3% increase in revenue to $6.533 million from $5.17 million
a year ago, according to the mean estimate from 3 analysts,
based on LSEG data.
* LSEG's mean analyst estimate for Clearpoint Neuro Inc is
for a
loss of 20 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Clearpoint
Neuro
Inc is $10.00, above its last closing price of $6.06.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM LSEG IBES ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT ESTIMATE MET, SE %
E® MISSED
Sep. 30 2023 -0.25 -0.25 -0.20 Beat 20
Jun. 30 2023 -0.19 -0.19 -0.29 Missed -52.6
Mar. 31 2023 -0.18 -0.18 -0.23 Missed -24.3
Dec. 31 2022 -0.20 -0.20 -0.18 Beat 10
Sep. -0.19 -0.19 -0.15 Beat 21.1
30 2022
Jun. 30 2022 -0.18 -0.18 Met 1.4
Mar. 31 2022 -0.20 -0.20 -0.17 Beat 15
Dec. 31 2021 -0.19 -0.19 -0.20 Missed -5.3
This summary was machine generated March 8 at 21:10 GMT. All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)